Active 0 6 0 6 O
Herpes 7 13 7 13 B-chronic_disease
Simplex 14 21 14 21 I-chronic_disease
or 22 24 22 24 O
Zoster 25 31 25 31 B-chronic_disease
at 32 34 32 34 O
the 35 38 35 38 O
time 39 43 39 43 O
of 44 46 44 46 O
treatment 47 56 47 56 O
or 57 59 57 59 O
having 60 66 60 66 O
experienced 67 78 67 78 O
more 79 83 79 83 O
than 84 88 84 88 O
three 89 94 89 94 B-lower_bound
episodes 95 103 95 103 O
of 104 106 104 106 O
Herpes 107 113 107 113 O
Simplex 114 121 114 121 O
/ 122 123 122 123 O
Zoster 124 130 124 130 B-chronic_disease
eruption 131 139 131 139 I-chronic_disease
within 140 146 140 146 O
a 147 148 147 148 O
year 149 153 149 153 O
of 154 156 154 156 O
study 157 162 157 162 O
enrollment 163 173 163 173 O

Adverse 0 7 174 181 O
reactions 8 17 182 191 O
to 18 20 192 194 O
compounds 21 30 195 204 O
of 31 33 205 207 O
any 34 37 208 211 O
external 38 46 212 220 O
agent 47 52 221 226 O
( 53 54 227 228 O
e.g. 54 58 228 232 O
, 58 59 232 233 O
gels 60 64 234 238 B-allergy_name
, 64 65 238 239 O
lotions 66 73 240 247 B-allergy_name
or 74 76 248 250 O
anesthetic 77 87 251 261 B-allergy_name
creams 88 94 262 268 I-allergy_name
) 94 95 268 269 O
required 96 104 270 278 O
for 105 108 279 282 O
use 109 112 283 286 O
in 113 115 287 289 O
the 116 119 290 293 O
study 120 125 294 299 O
, 125 126 299 300 O
if 127 129 301 303 O
no 130 132 304 306 O
alternative 133 144 307 318 O
to 145 147 319 321 O
the 148 151 322 325 O
said 152 156 326 330 O
agent 157 162 331 336 O
exists 163 169 337 343 O

All 0 3 344 347 O
wounds 4 10 348 354 O
in 11 13 355 357 O
the 14 17 358 361 O
area 18 22 362 366 O
of 23 25 367 369 O
interest 26 34 370 378 O
must 35 39 379 383 O
be 40 42 384 386 O
closed 43 49 387 393 O
for 50 53 394 397 O
at 54 56 398 400 O
least 57 62 401 406 O
two 63 66 407 410 B-lower_bound
months 67 73 411 417 I-lower_bound

Fitzpatrick 0 11 418 429 B-clinical_variable
skin 12 16 430 434 I-clinical_variable
types 17 22 435 440 I-clinical_variable
I 23 24 441 442 B-lower_bound
- 24 25 442 443 O
VI 25 27 443 445 B-upper_bound

Healthy 0 7 446 453 O
males 8 13 454 459 B-gender

History 0 7 460 467 O
of 8 10 468 470 O
collagen 11 19 471 479 B-chronic_disease
vascular 20 28 480 488 I-chronic_disease
disease 29 36 489 496 I-chronic_disease

History 0 7 497 504 O
of 8 10 505 507 O
immunosuppression 11 28 508 525 B-chronic_disease
/ 28 29 525 526 I-chronic_disease
immune 29 35 526 532 I-chronic_disease
deficiency 36 46 533 543 I-chronic_disease
disorders 47 56 544 553 I-chronic_disease
( 57 58 554 555 O
including 58 67 555 564 O
human 68 73 565 570 B-chronic_disease
immunodeficiency 74 90 571 587 I-chronic_disease
virus 91 96 588 593 I-chronic_disease
( 97 98 594 595 I-chronic_disease
HIV 98 101 595 598 I-chronic_disease
) 101 102 598 599 I-chronic_disease
infection 103 112 600 609 I-chronic_disease
or 113 115 610 612 O
acquired 116 124 613 621 B-chronic_disease
immunodeficiency 125 141 622 638 I-chronic_disease
syndrome 142 150 639 647 I-chronic_disease
( 151 152 648 649 I-chronic_disease
AIDS 152 156 649 653 I-chronic_disease
) 156 157 653 654 I-chronic_disease
or 158 160 655 657 O
use 161 164 658 661 O
of 165 167 662 664 O
immunosuppressive 168 185 665 682 B-treatment
medications 186 197 683 694 I-treatment

Participation 0 13 695 708 O
in 14 16 709 711 O
another 17 24 712 719 O
interventional 25 39 720 734 O
study 40 45 735 740 O
with 46 50 741 745 O
potential 51 60 746 755 O
exposure 61 69 756 764 O
to 70 72 765 767 O
an 73 75 768 770 O
investigational 76 91 771 786 O
drug 92 96 787 791 O
within 97 103 792 798 O
past 104 108 799 803 B-upper_bound
30 109 111 804 806 I-upper_bound
days 112 116 807 811 I-upper_bound

Patient 0 7 812 819 O
on 8 10 820 822 O
chemotherapy 11 23 823 835 B-treatment
( 24 25 836 837 O
but 25 28 837 840 O
not 29 32 841 844 O
tamoxifen 33 42 845 854 B-treatment
or 43 45 855 857 O
other 46 51 858 863 O
things 52 58 864 870 O
that 59 63 871 875 O
affect 64 70 876 882 O
wound 71 76 883 888 O
healing 77 84 889 896 O
) 84 85 896 897 O
and 86 89 898 901 O
also 90 94 902 906 O
active 95 101 907 913 O
XRT 102 105 914 917 B-clinical_variable

Pregnant 0 8 918 926 B-pregnancy
woman 9 14 927 932 B-gender
can 15 18 933 936 O
be 19 21 937 939 O
included 22 30 940 948 O
because 31 38 949 956 O
study 39 44 957 962 O
involves 45 53 963 971 O
local 54 59 972 977 O
intervention 60 72 978 990 O
, 72 73 990 991 O
no 74 76 992 994 O
new 77 80 995 998 O
drugs 81 86 999 1004 O

Prior 0 5 1005 1010 B-treatment
skin 6 10 1011 1015 I-treatment
treatment 11 20 1016 1025 I-treatment
with 21 25 1026 1030 I-treatment
laser 26 31 1031 1036 I-treatment
or 32 34 1037 1039 I-treatment
other 35 40 1040 1045 I-treatment
devices 41 48 1046 1053 I-treatment
in 49 51 1054 1056 O
the 52 55 1057 1060 O
treated 56 63 1061 1068 O
area 64 68 1069 1073 O
within 69 75 1074 1080 O
three 76 81 1081 1086 B-upper_bound
months 82 88 1087 1093 I-upper_bound
of 89 91 1094 1096 O
initial 92 99 1097 1104 B-treatment
treatment 100 109 1105 1114 I-treatment
or 110 112 1115 1117 O
during 113 119 1118 1124 O
the 120 123 1125 1128 O
course 124 130 1129 1135 O
of 131 133 1136 1138 O
the 134 137 1139 1142 O
study 138 143 1143 1148 O

Significant 0 11 1149 1160 O
concurrent 12 22 1161 1171 O
illness 23 30 1172 1179 O
, 30 31 1179 1180 O
such 32 36 1181 1185 O
as 37 39 1186 1188 O
uncontrolled 40 52 1189 1201 B-chronic_disease
diabetes 53 61 1202 1210 I-chronic_disease
( 62 63 1211 1212 O
with 63 67 1212 1216 O
a 68 69 1217 1218 O
hemoglobin 70 80 1219 1229 B-clinical_variable
A1C 81 84 1230 1233 I-clinical_variable
of 85 87 1234 1236 O
more 88 92 1237 1241 O
than 93 97 1242 1246 O
8) 98 100 1247 1249 B-lower_bound
( 101 102 1250 1251 O
i.e. 102 106 1251 1255 O
, 106 107 1255 1256 O
any 108 111 1257 1260 O
disease 112 119 1261 1268 O
state 120 125 1269 1274 O
that 126 130 1275 1279 O
in 131 133 1280 1282 O
the 134 137 1283 1286 O
opinion 138 145 1287 1294 O
of 146 148 1295 1297 O
the 149 152 1298 1301 O
Investigator 153 165 1302 1314 O
would 166 171 1315 1320 O
interfere 172 181 1321 1330 O
with 182 186 1331 1335 O
the 187 190 1336 1339 O
anesthesia 191 201 1340 1350 B-treatment
, 201 202 1350 1351 O
treatment 203 212 1352 1361 B-treatment
, 212 213 1361 1362 O
or 214 216 1363 1365 O
healing 217 224 1366 1373 O
process 225 232 1374 1381 O
) 232 233 1381 1382 O
; 233 234 1382 1383 O
Mentally 235 243 1384 1392 B-chronic_disease
incompetent 244 255 1393 1404 I-chronic_disease
, 255 256 1404 1405 O
prisoner 257 265 1406 1414 O
or 266 268 1415 1417 O
evidence 269 277 1418 1426 O
of 278 280 1427 1429 O
active 281 287 1430 1436 O
substance 288 297 1437 1446 O
or 298 300 1447 1449 O
alcohol 301 308 1450 1457 O
abuse 309 314 1458 1463 O

The 0 3 1464 1467 O
scars 4 9 1468 1473 O
must 10 14 1474 1478 O
be 15 17 1479 1481 O
deemed 18 24 1482 1488 O
stable 25 31 1489 1495 O
for 32 35 1496 1499 O
a 36 37 1500 1501 O
period 38 44 1502 1508 O
of 45 47 1509 1511 O
3 48 49 1512 1513 B-upper_bound
months 50 56 1514 1520 I-upper_bound
or 57 59 1521 1523 O
have 60 64 1524 1528 O
a 65 66 1529 1530 O
suitable 67 75 1531 1539 O
contralateral 76 89 1540 1553 O
control 90 97 1554 1561 O
before 98 104 1562 1568 O
initiation 105 115 1569 1579 O
of 116 118 1580 1582 O
treatment 119 128 1583 1592 O
. 128 129 1592 1593 O
This 130 134 1594 1598 O
will 135 139 1599 1603 O
be 140 142 1604 1606 O
determined 143 153 1607 1617 O
by 154 156 1618 1620 O
objective 157 166 1621 1630 O
measurements 167 179 1631 1643 O
of 180 182 1644 1646 O
scar 183 187 1647 1651 B-chronic_disease
erythema 188 196 1652 1660 I-chronic_disease
, 196 197 1660 1661 O
pliability 198 208 1662 1672 O
, 208 209 1672 1673 O
induration 210 220 1674 1684 O
, 220 221 1684 1685 O
thickness 222 231 1686 1695 O
at 232 234 1696 1698 O
enrollment 235 245 1699 1709 O
and 246 249 1710 1713 O
again 250 255 1714 1719 O
at 256 258 1720 1722 O
3 259 260 1723 1724 O
months 261 267 1725 1731 O

between 0 7 1732 1739 O
18 8 10 1740 1742 B-lower_bound
and 11 14 1743 1746 O
80 15 17 1747 1749 B-upper_bound
years 18 23 1750 1755 I-upper_bound
of 24 26 1756 1758 O
age 27 30 1759 1762 B-age

females 0 7 1763 1770 B-gender

with 0 4 1771 1775 O
radiation 5 14 1776 1785 B-chronic_disease
- 14 15 1785 1786 I-chronic_disease
induced 15 22 1786 1793 I-chronic_disease
fibrosis 23 31 1794 1802 I-chronic_disease
and 32 35 1803 1806 O
depigmentation 36 50 1807 1821 B-chronic_disease
. 50 51 1821 1822 O
The 52 55 1823 1826 O
fibrosis 56 64 1827 1835 O
must 65 69 1836 1840 O
have 70 74 1841 1845 O
occurred 75 83 1846 1854 O
at 84 86 1855 1857 O
least 87 92 1858 1863 O
1 93 94 1864 1865 B-lower_bound
year 95 99 1866 1870 I-lower_bound
prior 100 105 1871 1876 I-lower_bound
to 106 108 1877 1879 O
the 109 112 1880 1883 O
date 113 117 1884 1888 O
of 118 120 1889 1891 O
enrollment 121 131 1892 1902 O

